
Gene knockout cell lines are generated using CRISPR-Cas9 based technology to precisely disrupt target genes, enabling functional genomics research, disease modeling, and target validation.
ZMAT3 (zinc finger matrin-type 3) encodes a nuclear zinc finger-containing protein involved in transcriptional regulation. Its expression is induced by wild-type p53, and increased ZMAT3 expression can inhibit tumor cell growth, supporting a role in p53-dependent growth regulation. Through its nuclear localization and zinc finger domains, ZMAT3 may contribute to cellular responses that regulate proliferation and maintenance of appropriate cell growth.
Human normal colonic epithelial cells are represented by NCM460, a cell line derived from normal colonic mucosa rather than a malignant tumor. The cells are classified as human intestinal epithelial cells and are commonly used as a non-tumorigenic intestinal epithelial model.
Before delivery, each clone is authenticated by STR, tested for sterility and mycoplasma, and genotype‑verified by two‑round PCR‑sequencing. Comprehensive QC data accompany every shipment to support reproducible research.

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations
These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.
Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.

Targeted knockout region: EExon 2
Reference Transcript: NM_001375827
Frameshift Mutation Strategy
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use





Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours.
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?